insights_auto
Why is SABS down ၃.၉၀%?
Dive Deeperchevron_right
SABS:NASDAQ
SAB Biotherapeutics Inc
၂.၉၆ US$
arrow_downward
-၃.၉၀%(-၀.၁၂) 1D
နို ၁၃, GMT-၅ ၁၆:၀၀:၀၀ · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for SABS...
Open
၃.၀၈ US$
High
၃.၁၅ US$
Low
၂.၈၅ US$
Mkt. cap
၂၆.၆၇ ကုဋေ
Avg. vol.
၇.၀၀ သိန်း
Volume
၆.၅၈ သိန်း
52-wk high
၅.၁၅ US$
52-wk low
၂.၄၄ US$
EPS
-၀.၉၃ US$
Beta
၀.၆၇
Shares outstanding
၉.၀၁ ကုဋေ
No. of employees
၈၆
Open
၃.၀၈ US$
High
၃.၁၅ US$
Low
၂.၈၅ US$
Mkt. cap
၂၆.၆၇ ကုဋေ
Avg. vol.
၇.၀၀ သိန်း
Volume
၆.၅၈ သိန်း
52-wk high
၅.၁၅ US$
52-wk low
၂.၄၄ US$
EPS
-၀.၉၃ US$
Beta
၀.၆၇
Shares outstanding
၉.၀၁ ကုဋေ
No. of employees
၈၆
News stories
From web sources and news partners
investingLive
·
ပြီးခဲ့သည့် ၃ နာရီ
Morgan Stanley goes max overweight global stocks, sees 15% S&P 500 upside on AI capex
The Motley Fool
·
ပြီးခဲ့သည့် ၁၀ နာရီ
This Dividend King Yields 5 Times the S&P 500. Is It a Buy Now?
TradingKey
·
ပြီးခဲ့သည့် ၁ ရက်
S&P 500 Forecast: Index Poised to Retest Record High in November After 500-Point Pullback, Biggest Daily Gain in Nearly Seven Months
BigGo Finance
·
ပြီးခဲ့သည့် ၁၆ နာရီ
Goldman Sachs Sets 8,700 S&P 500 Target for 2027, Sees 14% Upside as AI Capex Peaks
About SAB Biotherapeutics Inc
CEO-
Employees၈၆
Founded၂၀၁၄
HeadquartersMiami Beach, ဖလော်ရီဒါပြည်နယ်, ယူနိုက်တက်စတိတ်
SectorHealth Care
Industry-
Websitesab.bio